Anakinra for severe forms of COVID-19: a cohort study

Anakinra reduced both need for invasive mechanical ventilation in the ICU and mortality among patients with severe forms of COVID-19, without serious side-effects. Confirmation of efficacy will require controlled trials.

Read the full article here

Related Articles